MedTrace Logo

LH/FSH, Testosterone, Prolactin, and Ferritin in PCOS Patients in Jordan

NCT07112768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2025-08-08

No results posted yet for this study

Summary

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder impacting women of reproductive age. Characterized by chronic anovulation, hyperandrogenism, and the presence of multiple small ovarian cysts. Despite its widespread occurrence, a comprehensive study particularly within the Jordanian population remains limited. Aim of the study: The study aimed to assess the serum levels of the Luteinizing hormone (LH), Follicle stimulating hormone (FSH), LH/FSH ratio, Testosterone, Prolactin, and Ferritin in Jordanian women diagnosed with PCOS

Conditions

  • PCOS (Polycystic Ovary Syndrome)

Interventions

DIAGNOSTIC_TEST

Serum levels of LH, FSH, testosterone, prolactin, and ferritin

Measurement of both hormonal and biochemical markers in Jordanian PCOs females, including Serum levels of LH, FSH, testosterone, prolactin, and ferritin)

Sponsors & Collaborators

  • Future University in Egypt

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-02
Primary Completion
2024-04-10
Completion
2024-04-22

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07112768 on ClinicalTrials.gov